Coya Therapeutics, Inc. (COYA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.21M | -1.01M | -1.13M | -5.77M | -2.83M | -2.41M | -5.46M | -4.56M | 2.15M | -2.24M | -2.22M | -2.87M |
| Operating CF Margin % | -2472.07% | -25.43% | -31.72% | -3528.56% | -1096.72% | -123451.18% | - | -133.23% | 1691.82% | -37.34% | - | - |
| Operating CF Growth % | -119.52% | 58.21% | 79.3% | -26.51% | -231.8% | -7.53% | -146.44% | -59.13% | 155.54% | -0.81% | -39.24% | -99.15% |
| Net Income | -7.21M | -5.71M | -2.12M | -6.09M | -7.31M | -2.92M | -4.02M | -2.89M | -5.05M | 1.27M | -3.42M | -3.1M |
| Depreciation & Amortization | 2.81K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K | 6.84K |
| Stock-Based Compensation | 0 | 0 | 1.07M | 1.04M | 1.08M | 790.55K | 775.01K | 662.32K | 435.66K | 238K | 262.75K | 191.11K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 225.05K | 119.94K | 729.64K |
| Other Non-Cash Items | 2.21M | 2.88M | 516K | 0 | 0 | 0 | 0 | 0 | 25K | -31.86K | -119.94K | -379.64K |
| Working Capital Changes | -1.21M | 1.82M | -608.5K | -720.87K | 3.39M | -291.38K | -2.22M | -2.34M | 6.73M | -3.95M | 936.27K | -320.47K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.5M | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -154.71K | -50.58K | 180.36K | -758.66K | 101.88K | 1.25M | -1.49M | 238.8K | 477.26K | 476.73K | 396.37K | -304.17K |
| Cash from Investing | -885K | -648.61K | -516K | 0 | 0 | 0 | 0 | 0 | -25K | -193.19K | 0 | -350K |
| Capital Expenditures | -885K | -648.61K | 0 | 0 | 0 | 0 | 0 | 0 | -25K | 0 | 0 | 0 |
| CapEx % of Revenue | 352.38% | 16.38% | - | - | - | - | - | - | 19.71% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -516K | 0 | 0 | 0 | 0 | 0 | 0 | -193.19K | 0 | -350K |
| Cash from Financing | 11M | 20.35M | 19.14K | 0 | 19.14K | 9.69M | -56.33K | 5.15M | 1.24M | 24.17M | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.25M |
| Equity Issued (Net) | 11M | 20.35M | 19.14K | 0 | 19.14K | 9.68M | -56.33K | 5M | 1.24M | 24.08M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 11.25K | 0 | 149.25K | 0 | 89.95K | 0 | 14.25M |
| Net Change in Cash | 3.9M | 18.69M | -1.63M | -5.77M | -2.81M | 7.28M | -5.52M | 585.68K | 3.36M | 21.74M | -2.22M | -3.22M |
| Free Cash Flow | -6.21M | -1.01M | -1.13M | -5.77M | -2.83M | -2.41M | -5.46M | -4.56M | 2.15M | -2.24M | -2.22M | -2.87M |
| FCF Margin % | -2472.07% | -25.43% | -31.72% | -3528.56% | -1096.72% | -123451.18% | - | -133.23% | 1691.82% | -37.34% | - | - |
| FCF Growth % | -119.52% | 58.21% | 79.3% | -26.51% | -231.8% | -7.53% | -146.44% | -59.13% | 155.54% | -0.81% | -39.24% | -99.15% |
| FCF per Share | -0.37 | -0.06 | -0.07 | -0.35 | -0.17 | -0.15 | -0.36 | -0.31 | 0.15 | -0.22 | -0.22 | -0.29 |
| FCF Conversion (FCF/Net Income) | 0.86x | 0.18x | 0.53x | 0.95x | 0.39x | 0.83x | 1.36x | 1.58x | -0.42x | -1.77x | 0.65x | 0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |